Brief: EQL Pharma Q4 EBIT SEK 8.4 Million
14/05/2024 19:15
May 14 (Reuters) - EQL Pharma Q4 adjusted free cash flow SEK -2.9 million. * Q4 EBIT margin 11% * Q4 revenue SEK 78.1 million
EQL — EQL Pharma AB News Story
0.000.00%
Last trade - 00:00- SEK670.32m
- SEK1.07bn
- SEK432.66m